Workshop 3: Experimental Subjects

Date

14 January, 2010 - 15 January, 2010

Location

Institute for Advanced Studies, Lancaster University

Description

Participants in this workshop explored the different kinds of subjectivity and relations of power produced by different forms of experimentality. Themes included:

  • ‘experimental subjects’, such as subjects of clinical trials or of behaviourist-inspired public policy interventions;
  • the self as the site of self-experimentation in popular culture, alternative spirituality, performance art, and human resource discourses
  • the experimenter as a form of subjectivity in science, technology, and finance capital.

The workshop started at 13.45 on 14 January and ended at 16.30 on 15 January, and included a private viewing of Experimentality Photography Exhibition. For the original programme, click here

Thursday 14 January

13.45 – 14.00 Introduction

Bronislaw Szerszynski (Sociology, Lancaster University)

14.00 – 15.00

Kaushik Sunder Rajan (Anthropology, University of California Irvine) ‘Conceptualizing the experimental subject of global clinical trials’

15.30 – 17.00

Laurence Hemming (IAS, Lancaster) ‘The joy and danger of experimentation’

Bronislaw Szerszynski (Sociology, Lancaster University) ‘Experimental time and the event of politics’

Friday 20 November

09.30 – 11.00

Lisa Blackman (Media and Communications, Goldsmiths) ‘Experimenting with suggestion: performing ‘social influence’ processes’.

Alan Collins (Psychology, Lancaster University)
‘On the history of experimental psychology’

11.30 – 13.00

Neal White (Office of Experiments and Media School, Bournemouth University) ‘Experimentality. The Experimental Site’

Rod Dickinson (School of Creative Arts, University of the West of England) ‘Experiments with an Audience’

14.00 – 15.30

Brian Balmer and Norma Morris (Science and Technology Studies, UCL) 'Who is the 'guinea-pig' in human experimentation?'

Linsey McGoey (Science and Technology Studies, Oxford) ‘Experimental dissidence: economies of credibility in drug regulation’

15.45 – 16.30 Round table discussion